NCT04950374

A Clinical Trial to Evaluate the Safety and Efficacy of a Moisturizer Body Lotion and a Lip Moisturizer in Adults of Atopic Dermatitis.

Single Center, Open-label, Non-randomized Clinical Trial to Evaluate the Safety and Efficacy of a Moisturizer Body Lotion and the Safety and Perceived Efficacy of a Lip Moisturizer in Adults With Atopic Dermatitis Presenting Dermatological Lesion.

• Status: Withdrawn
• Phase: N/A
• Study type: Interventional
• Enrollment: 0 (actual)
• Sponsor: Johnson & Johnson Consumer Inc. (J&JCI) · Industry
• Sex: All
• Age: 18 Years – 59 Years
• Healthy volunteers: Not accepted

Summary

This study will test the safety and efficacy of 2 moisturizers: a body lotion and a lip moisturizer. For the moisturizer body lotion, the study aims to determine the tolerance of this product by the study population, and its effects on atopic dermatitis condition, skin hydration, skin barrier, skin microbiome and perceived efficacy. For the lip moisturizer, the study aims to determine the tolerance of this product by the same study population and its effects on the perceived efficacy. Participants will receive both products and use them at home for 21 +/- 2 days.

Conditions

• Atopic Dermatitis

Interventions

Type	Name	Description
OTHER	Moisturizer Body Lotion	The body lotion product is a moisturizing formulation intended for topical use on the whole body and face. It will be applied at least twice daily.
OTHER	Lip Moisturizer	The lip product is a moisturizing formulation intended for topical use on the lips. It will be applied at least twice daily.

Timeline

• Start date: 2021-07-26
• Primary completion: 2021-11-26
• Completion: 2021-12-10
• First posted: 2021-07-06
• Last updated: 2021-09-08